文献速递瓣膜外科

Trifecta与Intuity瓣膜行主动脉瓣置换术后的长期耐久性比较分析

Long-term durability after surgical aortic valve replacement with the Trifecta and the Intuity valve-a comparative analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2022-01-01

单中心比较346例Trifecta与772例Intuity生物瓣行SAVR后的结构性瓣膜衰败(SVD)。Trifecta组SVD累积发生率显著更高(P<0.001),瓣膜类型为SVD和再次干预的独立危险因素,全因死亡无显著差异(P=0.052)。

要点

  • Trifecta组SVD累积发生率显著高于Intuity组(P<0.001)。
  • Trifecta植入是SVD的独立危险因素(HR 11.20;95%CI 3.79-33.09)。
  • Trifecta组再次干预累积发生率显著更高(P=0.004)。

核心结论

  • 接受Trifecta瓣膜的患者SVD显著更频繁,其植入是SVD和主动脉瓣再次干预的独立危险因素。
  • 该两种低跨瓣压差生物瓣的比较分析对Trifecta瓣膜的长期耐久性提出质疑,行生物瓣SAVR时需加以考虑。

研究设计与样本

  • 单中心比较分析,2010年4月至2020年5月共1118例患者行SAVR,Trifecta组346例、Intuity组772例。
  • 排除单纯反流和心内膜炎患者后分析1070例(Trifecta组298例、Intuity组772例),进行回顾性和前瞻性超声心动图及临床随访。
  • 采用Cox比例风险回归模型识别SVD、主动脉再干预和死亡的预后因素。

主要发现

  • 共观察27例SVD(Trifecta组23例、Intuity组4例),Trifecta组SVD累积发生率显著更高(P<0.001)。
  • SVD的预后因素包括Trifecta瓣膜植入(HR 11.20;95%CI 3.79-33.09)、对数转换的术前肌酐(HR 2.47;95%CI 1.37-4.44)和性别(男性HR 0.42;95%CI 0.19-0.92)。
  • Trifecta组再次干预累积发生率显著更高(P=0.004),瓣膜类型为独立的时间依存性危险因素(12个月时HR 2.78;95%CI 1.42-5.45)。
  • 两组全因死亡率无显著差异(log-rank检验:P=0.052)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Long-term durability of surgical bio-prostheses is a key factor, especially in the era of transcatheter aortic valve replacement. We compared the incidence of structural valve deterioration (SVD) between patients undergoing surgical aortic valve replacement (SAVR) with the Trifecta (Abbott Laboratories, Abbott Park, IL, USA) or the Intuity valve (Edwards Lifesciences, Irvine, CA, USA). METHODS: Between April 2010 and May 2020, 1118 patients underwent SAVR with the Trifecta (n = 346) and the Intuity (n = 772) valve at a single centre. A total of 1070 patients (Trifecta n = 298, Intuity n = 772) were analysed after the exclusion of patients with pure regurgitation and endocarditis. Retro- and prospective echocardiographic and clinical follow-up was performed. Cox proportional hazards regression models were performed to identify prognostic factors for SVD, aortic re-interventions and mortality. RESULTS: With 27 cases (Trifecta n = 23, Intuity n = 4) of SVD observed, cumulative incidence of SVD was significantly higher in the Trifecta cohort (P < 0.001). Implantation of a Trifecta valve [hazard ratio (HR) 11.20; 95% confidence interval 3.79-33.09], log-transformed preoperative creatinine (HR 2.47; 1.37-4.44) and sex (male HR 0.42; 0.19-0.92) emerged as prognostic factors of SVD. A significantly higher cumulative incidence of re-interventions was observed in the Trifecta cohort (P = 0.004) and valve type was an independent time-varying risk factor (HR at 12 months 2.78; 95% confidence interval 1.42-5.45). Overall, no significant differences in all-cause mortality were observed between the groups (log-rank test: P = 0.052). CONCLUSIONS: SVD was significantly more frequent in patients receiving a Trifecta valve and its implantation was an independent risk factor for the occurrence of SVD and aortic valve re-interventions. This comparative analysis of 2 low-gradient bioprosthesis put the long-term durability of the Trifecta valve in question and need to be taken into consideration when performing bioprosthetic SAVR.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Werner P, Coti I, Kaider A, et al. Long-term durability after surgical aortic valve replacement with the Trifecta and the Intuity valve-a comparative analysis. Eur J Cardiothorac Surg. 2022. PMID: 34738111. doi:10.1093/ejcts/ezab470

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。